Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Lessons from lipids in the fight against influenza.

García-Sastre A.

Cell. 2013 Jul 3;154(1):22-3. doi: 10.1016/j.cell.2013.06.024.

2.

The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza.

Morita M, Kuba K, Ichikawa A, Nakayama M, Katahira J, Iwamoto R, Watanebe T, Sakabe S, Daidoji T, Nakamura S, Kadowaki A, Ohto T, Nakanishi H, Taguchi R, Nakaya T, Murakami M, Yoneda Y, Arai H, Kawaoka Y, Penninger JM, Arita M, Imai Y.

Cell. 2013 Mar 28;153(1):112-25. doi: 10.1016/j.cell.2013.02.027. Epub 2013 Mar 7.

3.

Lipidomic profiling of influenza infection identifies mediators that induce and resolve inflammation.

Tam VC, Quehenberger O, Oshansky CM, Suen R, Armando AM, Treuting PM, Thomas PG, Dennis EA, Aderem A.

Cell. 2013 Jul 3;154(1):213-27. doi: 10.1016/j.cell.2013.05.052.

4.

Proinflammatory cytokine response and viral replication in mouse bone marrow derived macrophages infected with influenza H1N1 and H5N1 viruses.

Chan RW, Leung CY, Nicholls JM, Peiris JS, Chan MC.

PLoS One. 2012;7(11):e51057. doi: 10.1371/journal.pone.0051057. Epub 2012 Nov 30.

5.

The influenza virus enigma.

Salomon R, Webster RG.

Cell. 2009 Feb 6;136(3):402-10. doi: 10.1016/j.cell.2009.01.029.

6.

Evaluation of the efficacy and safety of a statin/caffeine combination against H5N1, H3N2 and H1N1 virus infection in BALB/c mice.

Liu Z, Guo Z, Wang G, Zhang D, He H, Li G, Liu Y, Higgins D, Walsh A, Shanahan-Prendergast L, Lu J.

Eur J Pharm Sci. 2009 Oct 8;38(3):215-23. doi: 10.1016/j.ejps.2009.07.004. Epub 2009 Jul 16.

PMID:
19616097
7.

[Influenza virus reproduction in the endothelial cells of human blood vessels].

Zhilinskaia IN, Azarenok AA, Il'inskaia EV, Prochukhanova AR, Vorob'ev SL, Sorokin EV, Tsareva TR.

Vopr Virusol. 2012 Mar-Apr;57(2):20-3. Russian.

PMID:
22834142
8.

Avian influenza. Hybrid viruses fail to spread.

Kaiser J.

Science. 2006 Aug 4;313(5787):601-2. No abstract available.

PMID:
16888110
9.

Influenza virus NS1 protein protects against lymphohematopoietic pathogenesis in an in vivo mouse model.

Hyland L, Webby R, Sandbulte MR, Clarke B, Hou S.

Virology. 2006 May 25;349(1):156-63. Epub 2006 Mar 20.

10.

Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets.

Huang SS, Banner D, Fang Y, Ng DC, Kanagasabai T, Kelvin DJ, Kelvin AA.

PLoS One. 2011;6(11):e27512. doi: 10.1371/journal.pone.0027512. Epub 2011 Nov 16.

11.

Temperature sensitivity on growth and/or replication of H1N1, H1N2 and H3N2 influenza A viruses isolated from pigs and birds in mammalian cells.

Massin P, Kuntz-Simon G, Barbezange C, Deblanc C, Oger A, Marquet-Blouin E, Bougeard S, van der Werf S, Jestin V.

Vet Microbiol. 2010 May 19;142(3-4):232-41. doi: 10.1016/j.vetmic.2009.10.012. Epub 2009 Oct 28.

PMID:
19926410
12.

Attachment of infectious influenza A viruses of various subtypes to live mammalian and avian cells as measured by flow cytometry.

Rimmelzwaan GF, Nieuwkoop NJ, de Mutsert G, Boon AC, Kuiken T, Fouchier RA, Osterhaus AD.

Virus Res. 2007 Nov;129(2):175-81. Epub 2007 Aug 22.

PMID:
17714820
13.

Receptor tyrosine kinase inhibitors that block replication of influenza a and other viruses.

Kumar N, Sharma NR, Ly H, Parslow TG, Liang Y.

Antimicrob Agents Chemother. 2011 Dec;55(12):5553-9. doi: 10.1128/AAC.00725-11. Epub 2011 Sep 19.

14.

Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses.

Li IW, Chan KH, To KW, Wong SS, Ho PL, Lau SK, Woo PC, Tsoi HW, Chan JF, Cheng VC, Zheng BJ, Chen H, Yuen KY.

J Clin Virol. 2009 Dec;46(4):325-30. doi: 10.1016/j.jcv.2009.09.013. Epub 2009 Oct 3.

PMID:
19801200
15.

Pandemic H1N1 vaccine requires the use of an adjuvant to protect against challenge in naïve ferrets.

Baras B, de Waal L, Stittelaar KJ, Jacob V, Giannini S, Kroeze EJ, van den Brand JM, van Amerongen G, Simon JH, Hanon E, Mossman SP, Osterhaus AD.

Vaccine. 2011 Mar 3;29(11):2120-6. doi: 10.1016/j.vaccine.2010.12.125. Epub 2011 Jan 14.

PMID:
21238573
16.

The aminobisphosphonate pamidronate controls influenza pathogenesis by expanding a gammadelta T cell population in humanized mice.

Tu W, Zheng J, Liu Y, Sia SF, Liu M, Qin G, Ng IH, Xiang Z, Lam KT, Peiris JS, Lau YL.

J Exp Med. 2011 Jul 4;208(7):1511-22. doi: 10.1084/jem.20110226. Epub 2011 Jun 27.

17.

The 3rd international conference on Influenza Vaccines for the World (IVW 2009).

Yedidia TB.

Hum Vaccin. 2009 Aug;5(8):508-9. Epub 2009 Aug 27. No abstract available.

PMID:
19556873
18.

In vitro inhibition of human influenza A virus replication by chloroquine.

Ooi EE, Chew JS, Loh JP, Chua RC.

Virol J. 2006 May 29;3:39.

19.

Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice.

Shi J, Wen Z, Guo J, Zhang Y, Deng G, Shu Y, Wang D, Jiang Y, Kawaoka Y, Bu Z, Chen H.

Antiviral Res. 2012 Mar;93(3):346-53. doi: 10.1016/j.antiviral.2012.01.001. Epub 2012 Jan 18.

PMID:
22281419
20.

Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes.

Pushko P, Pearce MB, Ahmad A, Tretyakova I, Smith G, Belser JA, Tumpey TM.

Vaccine. 2011 Aug 11;29(35):5911-8. doi: 10.1016/j.vaccine.2011.06.068. Epub 2011 Jun 30.

PMID:
21723354

Supplemental Content

Support Center